A detailed history of Bellevue Group Ag transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 6,377,115 shares of RLAY stock, worth $48.5 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
6,377,115
Previous 5,926,618 7.6%
Holding current value
$48.5 Million
Previous $49.2 Million 15.47%
% of portfolio
0.7%
Previous 0.77%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.9 - $8.02 $2.66 Million - $3.61 Million
450,497 Added 7.6%
6,377,115 $41.6 Million
Q1 2024

May 15, 2024

SELL
$7.5 - $12.07 $70,980 - $114,230
-9,464 Reduced 0.16%
5,926,618 $49.2 Million
Q4 2023

Feb 14, 2024

BUY
$6.01 - $11.48 $6.32 Million - $12.1 Million
1,051,082 Added 21.52%
5,936,082 $65.4 Million
Q3 2023

Nov 14, 2023

BUY
$8.24 - $12.97 $5.89 Million - $9.26 Million
714,200 Added 17.12%
4,885,000 $41.1 Million
Q2 2023

Aug 14, 2023

SELL
$9.99 - $18.27 $17,982 - $32,886
-1,800 Reduced 0.04%
4,170,800 $52.4 Million
Q1 2023

May 15, 2023

SELL
$15.0 - $22.76 $483,300 - $733,327
-32,220 Reduced 0.77%
4,172,600 $68.7 Million
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $3.12 Million - $5.41 Million
172,558 Added 4.28%
4,204,820 $94.1 Million
Q2 2022

Aug 11, 2022

BUY
$13.31 - $34.88 $1.51 Million - $3.95 Million
113,300 Added 2.89%
4,032,262 $67.5 Million
Q1 2022

May 13, 2022

SELL
$20.26 - $32.36 $3.79 Million - $6.05 Million
-187,000 Reduced 4.55%
3,918,962 $117 Million
Q4 2021

Feb 10, 2022

BUY
$26.0 - $37.03 $9.1 Million - $13 Million
350,000 Added 9.32%
4,105,962 $126 Million
Q3 2021

Nov 12, 2021

BUY
$29.75 - $37.99 $33.2 Million - $42.4 Million
1,115,000 Added 42.22%
3,755,962 $118 Million
Q2 2021

Aug 12, 2021

BUY
$27.5 - $38.19 $19.5 Million - $27.1 Million
709,618 Added 36.74%
2,640,962 $96.6 Million
Q1 2021

May 12, 2021

BUY
$32.52 - $61.53 $17 Million - $32.1 Million
521,987 Added 37.04%
1,931,344 $66.8 Million
Q4 2020

Feb 16, 2021

BUY
$35.51 - $54.03 $3.88 Million - $5.91 Million
109,357 Added 8.41%
1,409,357 $58.6 Million
Q3 2020

Nov 16, 2020

BUY
$32.81 - $45.1 $42.7 Million - $58.6 Million
1,300,000 New
1,300,000 $55.4 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $914M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.